Contraception Perspectives in Adolescents in Haiti

July 31, 2023 updated by: Abbey Masonbrink, Children's Mercy Hospital Kansas City

Barriers and Facilitators to Long-Acting Reversible Contraception: Perspectives of Adolescents and Healthcare Providers in Rural Haiti

The overall goal of this study is to assess facilitators and barriers to contraception with a focus on long-acting reversible contraception (LARC) among adolescents and health care providers (HCPs) in rural Haiti. The investigator plans to accomplish the following objectives:

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Objective 1: Develop locally-informed surveys and in-depth interview guides, based on the ecologically-expanded Theory of Planned Behavior, to assess attitudes, social norms, perceived behavioral control, and intentions regarding contraception, with a focus on LARC, among adolescents and HCPs in rural Haiti.

Objective 2: Conduct a formative mixed methods study of attitudes, social norms, perceived behavioral control, and intentions regarding contraception, with a focus on LARC, among female adolescents (N=150 survey, 25-50 in-depth interviews) and HCPs (N=15; survey and in-depth interviews) in rural Haiti.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Missouri
      • Kansas City, Missouri, United States, 64108
        • Children's Mercy Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 24 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adolescents 14-24 years old and health care providers in rural Haiti

Description

Inclusion Criteria:•

  • Adolescents who are biologically female and have reproductive potential (14-24 years old)
  • Adolescents who reside in the birthing clinic catchment area
  • Health care providers, including nurse midwives, who work at the local birthing clinic and providers at the local hospital

Exclusion Criteria:

-Subjects who are determined to have severe psychiatric illness or cognitive impairment (based on research team assessment).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Adolescents 14-24 years old
Other: Interviews/Surveys
This is a cross sectional survey and interviews of adolescents 14- 18 years old and HCPs living in rural Haiti
Health care providers in rural Haiti
Other: Interviews/Surveys
This is a cross sectional survey and interviews of adolescents 14- 18 years old and HCPs living in rural Haiti

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identification of facilitators and barriers to contraception use
Time Frame: Data collection will occur over one day for individual participants. Study data collection will occur over 18 months
The primary outcome is identification of facilitators and barriers to contraception use among adolescent participants based on responses to the eTPB domains described in Table 1. The investigator will also explore facilitators and barriers to contraception use among HCP participants.
Data collection will occur over one day for individual participants. Study data collection will occur over 18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Children's Mercy Hospital Kansas City

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 22, 2021

Primary Completion (Actual)

March 31, 2023

Study Completion (Actual)

July 31, 2023

Study Registration Dates

First Submitted

January 7, 2022

First Submitted That Met QC Criteria

February 19, 2022

First Posted (Actual)

February 23, 2022

Study Record Updates

Last Update Posted (Actual)

August 2, 2023

Last Update Submitted That Met QC Criteria

July 31, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00001626

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Contraception

Clinical Trials on Interviews/Surveys

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe